By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

M10.3 Gout due to impairment of renal function

AddAnalogsCompare
Found partially in the 25 (22) ⓘFound partially in the 25 drugs (22 of these, according to Kiberis statistics) in 0 selected books (authors) ... hide
  Effect Influence Cases ⓘ  Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • m10.3 gout due to impairment of renal function
  • 81%-8%10   Hidden. Need a subscription
  • 73%+15%15 read Kalium carbonicum
  • 72%+7%6 read Galium-heel
  • 72%+1%7 read Silica terra
    Kidney diseases - E 72% (I 1%, 7 cases.); Gout - E 17% (I -4%, 4 cases.)
  • 67%-4%8 read Reneel n
  • 63%+23%5 read Sanguinaria canadensis
  • 60%+13%5 read Calcarea phosphorica
  • 57%-1%17 read Phosphorus

    заболевания почек,подагра

    • 100% +12% 8 with «liver dysfunction»
    • 88% +13% 9 with «liver problems»
    • 83% +11% 11 with «diseases of the gastrointestinal tract»
    • On average: 57% -1% 17 
    • 38% -1% 6 with «hypertension»
    • 21% -12% 4 with «pain in the legs»
    • 21% -12% 4 with «sensations in the legs»
  • 57%+5%19 read Natrum sulphuricum

    заболевания почек,подагра

    • 70% +5% 9 with «violation of the function of both lungs»
    • On average: 57% 5% 19 
  • 56%+2%13 read Rhus toxicodendron
  • 56%+10%24 read Pulsatilla nigricans
    Kidney diseases - E 56% (I 10%, 24 cases.); Gout - E 61% (I 22%, 6 cases.)

    заболевания почек,подагра

    • On average: 56% 10% 24 
    • 24% -3% 9 with «hypertension»
  • 56%+16%4 read Tuberculinum bovinum kent
  • 50%+11%11 read Natrum muriaticum
    Kidney diseases - E 50% (I 11%, 11 cases.); Gout - E 26% (I -10%, 4 cases.)

    заболевания почек,подагра

    • 90% +37% 5 with «heart dysfunction»
    • On average: 50% 11% 11 
    • 12% -14% 4 with «inflammation»
    • 8% -21% 2 with «rashes on the head»
  • 42%-12%8 read Solidago compositum s
  • 41%+10%20 read Lycopodium clavatum

    заболевания почек,подагра

    • 64% +16% 8 with «diseases of the gastrointestinal tract»
    • On average: 41% 10% 20 
  • 39%-2%10 read Lachesis muta
  • 35%-7%5 read Belladonna
  • 34%+2%8 read Calcarea carbonica
    Kidney diseases - E 34% (I 2%, 8 cases.); Gout - E 47% (I 1%, 6 cases.)
  • 29%-4%8 read Sulphur
  • 11%-4%6 read Nux vomica
  • 11%-10%7 read Arsenicum album
  • 6%+3%10 read Causticum hahnemanni
  • Antisol read
  • Benzoicum acidum read
  • Colchicum autumnale read

Tree of ICD-10 diagnoses

  1. Description
  2. Related diseases
  3. Related clinical guidelines
  4. Related standards of medical care
  5. Basic medical services
  6. Clinics for treatment

Other names and synonyms

M10.3.

Description

There is no detailed description, see related

Related diseases

Related clinical guidelines

Related standards of medical care

42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.